Hims & Hers Health (HIMS) Scheduled to Post Quarterly Earnings on Monday

Hims & Hers Health (NYSE:HIMS) will be issuing its quarterly earnings data after the market closes on Monday, May 6th. Analysts expect the company to announce earnings of $0.02 per share for the quarter. Individual that are interested in participating in the company’s earnings conference call can do so using this link.

Hims & Hers Health (NYSE:HIMS) last released its quarterly earnings data on Monday, February 26th. The company reported $0.01 EPS for the quarter, beating the consensus estimate of ($0.02) by $0.03. Hims & Hers Health had a negative return on equity of 7.21% and a negative net margin of 2.70%. The company had revenue of $246.60 million for the quarter, compared to analyst estimates of $245.84 million. During the same period last year, the company posted ($0.05) earnings per share. The firm’s revenue was up 47.4% compared to the same quarter last year. On average, analysts expect Hims & Hers Health to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Hims & Hers Health Price Performance

Shares of NYSE HIMS opened at $11.25 on Friday. Hims & Hers Health has a 1-year low of $5.65 and a 1-year high of $17.16. The company has a market capitalization of $2.41 billion, a price-to-earnings ratio of -103.27 and a beta of 0.97. The business has a 50-day moving average of $13.97 and a 200-day moving average of $10.22.

Insiders Place Their Bets

In related news, CEO Andrew Dudum sold 50,361 shares of the company’s stock in a transaction that occurred on Wednesday, March 20th. The stock was sold at an average price of $16.34, for a total transaction of $822,898.74. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In related news, CEO Andrew Dudum sold 50,361 shares of the business’s stock in a transaction dated Wednesday, March 20th. The shares were sold at an average price of $16.34, for a total transaction of $822,898.74. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CFO Oluyemi Okupe sold 9,912 shares of the stock in a transaction dated Wednesday, March 20th. The stock was sold at an average price of $15.82, for a total transaction of $156,807.84. Following the sale, the chief financial officer now owns 168,627 shares in the company, valued at approximately $2,667,679.14. The disclosure for this sale can be found here. Insiders have sold a total of 736,191 shares of company stock valued at $9,733,700 in the last quarter. Insiders own 31.63% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on HIMS shares. Citigroup upped their price target on Hims & Hers Health from $12.00 to $16.00 and gave the stock a “buy” rating in a report on Tuesday, February 27th. Seaport Res Ptn reaffirmed a “buy” rating on shares of Hims & Hers Health in a research note on Friday, April 26th. Piper Sandler boosted their price objective on shares of Hims & Hers Health from $9.00 to $11.00 and gave the stock a “neutral” rating in a report on Tuesday, February 27th. Canaccord Genuity Group initiated coverage on Hims & Hers Health in a research note on Wednesday, April 10th. They set a “buy” rating and a $20.00 target price for the company. Finally, SVB Leerink assumed coverage on Hims & Hers Health in a research note on Monday, February 26th. They issued a “market perform” rating and a $10.00 price target on the stock. Five analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $14.85.

About Hims & Hers Health

Hims & Hers Health, Inc operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.